New Mexico Educational Retirement Board decreased its position in Humana Inc. (NYSE:HUM) by 11.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,382 shares of the insurance provider’s stock after selling 1,800 shares during the period. New Mexico Educational Retirement Board’s holdings in Humana were worth $3,094,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. BlackRock Inc. raised its position in Humana by 2,281.7% in the first quarter. BlackRock Inc. now owns 12,387,144 shares of the insurance provider’s stock worth $2,553,487,000 after buying an additional 11,867,056 shares in the last quarter. FMR LLC raised its position in Humana by 57.9% in the first quarter. FMR LLC now owns 5,050,853 shares of the insurance provider’s stock worth $1,041,184,000 after buying an additional 1,851,197 shares in the last quarter. Renaissance Technologies LLC raised its position in Humana by 84.3% in the first quarter. Renaissance Technologies LLC now owns 2,691,700 shares of the insurance provider’s stock worth $554,867,000 after buying an additional 1,231,400 shares in the last quarter. Wellington Management Group LLP raised its position in Humana by 2,651.1% in the first quarter. Wellington Management Group LLP now owns 775,755 shares of the insurance provider’s stock worth $159,915,000 after buying an additional 747,557 shares in the last quarter. Finally, AQR Capital Management LLC raised its position in Humana by 413.8% in the first quarter. AQR Capital Management LLC now owns 736,019 shares of the insurance provider’s stock worth $151,723,000 after buying an additional 592,772 shares in the last quarter. 99.66% of the stock is currently owned by institutional investors and hedge funds.

Shares of Humana Inc. (NYSE HUM) opened at 254.96 on Thursday. The stock has a 50 day moving average of $238.81 and a 200-day moving average of $222.35. Humana Inc. has a 1-year low of $163.50 and a 1-year high of $255.10. The firm has a market capitalization of $36.85 billion, a P/E ratio of 20.97 and a beta of 0.91.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $3.08 by $0.41. The company had revenue of $13.53 billion for the quarter, compared to analysts’ expectations of $13.61 billion. Humana had a net margin of 3.37% and a return on equity of 15.85%. During the same period in the prior year, the business earned $2.30 earnings per share. On average, equities analysts expect that Humana Inc. will post $11.55 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This article was posted by Daily Political and is owned by of Daily Political. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright law. The correct version of this article can be viewed at https://www.dailypolitical.com/2017/08/10/new-mexico-educational-retirement-board-sells-1800-shares-of-humana-inc-nysehum.html.

HUM has been the topic of a number of recent research reports. Zacks Investment Research raised shares of Humana from a “hold” rating to a “buy” rating and set a $237.00 price target on the stock in a research report on Tuesday, April 18th. Citigroup Inc. initiated coverage on shares of Humana in a research report on Wednesday, June 28th. They set a “buy” rating and a $275.00 price target on the stock. Evercore ISI reaffirmed an “outperform” rating and set a $240.00 price target on shares of Humana in a research report on Tuesday, April 25th. BidaskClub raised shares of Humana from a “hold” rating to a “buy” rating in a research report on Wednesday, June 21st. Finally, Jefferies Group LLC reaffirmed a “hold” rating and set a $230.00 price target (up from $221.00) on shares of Humana in a research report on Thursday, May 4th. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and twelve have issued a buy rating to the company. The company has an average rating of “Hold” and an average target price of $243.65.

In related news, VP Heidi S. Margulis sold 1,500 shares of the company’s stock in a transaction that occurred on Friday, May 26th. The shares were sold at an average price of $231.96, for a total value of $347,940.00. Following the transaction, the vice president now directly owns 8,150 shares in the company, valued at $1,890,474. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Brian P. Leclaire sold 4,971 shares of the company’s stock in a transaction that occurred on Wednesday, June 28th. The stock was sold at an average price of $240.00, for a total transaction of $1,193,040.00. Following the completion of the transaction, the senior vice president now owns 14,258 shares in the company, valued at $3,421,920. The disclosure for this sale can be found here. 0.80% of the stock is currently owned by corporate insiders.

Humana Company Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.